Strata Critical Medical, Inc.

SRTA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
9/30/2021
Operating Activities
Net Income-$27-$56-$27-$40
Dep. & Amort.$6$7$6$1
Deferred Tax-$0-$1-$1-$4
Stock-Based Comp.$20$13$0$10
Change in WC-$3-$7-$0-$2
Other Non-Cash$2$12-$15$20
Operating Cash Flow-$3-$32-$37-$16
Investing Activities
PP&E Inv.-$31-$2-$1-$0
Net Acquisitions-$2-$0-$48-$23
Inv. Purchases-$143-$266-$228-$309
Inv. Sales/Matur.$177$285$356$11
Other Inv. Act.-$2$0$0-$1
Investing Cash Flow-$1$17$79-$321
Financing Activities
Debt Repay.$0$0$0-$1
Stock Issued$0$0$0$120
Stock Repurch.-$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$6-$0-$1$214
Financing Cash Flow-$6-$0-$1$332
Forex Effect-$0-$0-$4$0
Net Chg. in Cash-$9-$15$37-$5
Supplemental Information
Beg. Cash$29$44$8$12
End Cash$20$29$44$8
Free Cash Flow-$36-$34-$38-$16
Strata Critical Medical, Inc. (SRTA) Financial Statements & Key Stats | AlphaPilot